Claims
- 1. A method of treating tumors in humans and animals, which comprises administering an effective amount of 1 to 100 mg/m.sup.2 of body surface per day of a compound selected from the group consisting of D/L-(2-adamantyl)- and D/L-(1-adamantyl-) glycyl-L-alanyl-D-isoglutamine of the formulae ##STR4## wherein R stands for a hydrogen atom or a MurNac group, and hydrochlorides thereof or a composition containing the same as an active ingredient.
- 2. The method of claim 1 wherein said compound is represented by formula 1(a) or its hydrochloride.
- 3. The method of claim 1 wherein said compound is represented by formula 1(b) or its hydrochloride.
- 4. The method of claim 1 herein said tumors are MCa mammary carcinoma tumors.
- 5. The method of claim 1 wherein said tumors melanoma b-16 tumors.
Priority Claims (1)
Number |
Date |
Country |
Kind |
305/89 |
Feb 1989 |
YUX |
|
Parent Case Info
This is a divisional of application Ser. No. 07/477,373, filed Feb. 9, 1990, now U.S. Pat. No. 5,066,642.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3705141 |
Krimmel |
Dec 1972 |
|
5066642 |
Vransic et al. |
Nov 1991 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
477373 |
Feb 1990 |
|